Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
West J Med ; 161(2): 160-1, 1994 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7941535

RESUMO

The Council on Scientific Affairs of the California Medical Association presents the following epitomes of progress in obstetrics and gynecology. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and clinical importance. The items are presented in simple epitome, and an authoritative reference, both to the item itself and to the subject as a whole, is generally given for those who may be unfamiliar with a particular item. The purpose is to assist busy practitioners, students, researchers, and scholars to stay abreast of progress in medicine, whether in their own field of special interest or another. The epitomes included here were selected by the Advisory Panel to the Section on Obstetrics and Gynecology of the California Medical Association, and the summaries were prepared under the direction of Dr Chang and the panel.


Assuntos
Complicações Infecciosas na Gravidez/microbiologia , Infecções Estreptocócicas/microbiologia , Streptococcus agalactiae , Adulto , Feminino , Humanos , Lactente , Recém-Nascido , Gravidez , Complicações Infecciosas na Gravidez/diagnóstico , Complicações Infecciosas na Gravidez/prevenção & controle , Resultado da Gravidez , Infecções Estreptocócicas/diagnóstico , Infecções Estreptocócicas/prevenção & controle , Infecções Estreptocócicas/transmissão
2.
Am J Obstet Gynecol ; 169(4): 775-82, 1993 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-8238131

RESUMO

OBJECTIVE: Our objective was to compare maternal and perinatal outcomes between two management schemes for women with preterm premature rupture of the membranes and documented fetal pulmonary maturity. STUDY DESIGN: Of 164 women with preterm premature rupture of the membranes at 32 weeks to 36 weeks 6 days' gestation, 93 eligible and consenting women were randomly selected for either induction of labor (n = 46) or expectant management (n = 47). Expectant management included hospitalization, assessment for fetal heart rate abnormalities, chorioamnionitis, and labor. Digital cervical examinations were prohibited until progressive labor occurred. Follow-up was also done for the 71 women who did not participate. RESULTS: The women in the induction of labor and expectant management groups had similar demographic characteristics and gestational ages (34.1 vs 34.3 weeks). Expectant management was associated with prolonged latencies to labor, delivery, and maternal hospitalization (p < 0.001), as well as increased hospitalization of infants at 2 to 5 days after delivery (p < 0.05). These patients had increased chorioamnionitis and fetal heart rate abnormalities before labor (p = 0.01, 0.03). Infants received more frequent (p < 0.001) and prolonged antimicrobial therapy after expectant management (p = 0.003) with no reduction in proven sepsis (6.8% vs 4.4%). These latter differences were influenced by the neonatologist's concern over potential neonatal infection. CONCLUSIONS: Among women with preterm premature rupture of the membranes at 32 to 36 weeks with mature surfactant profiles, immediate induction of labor reduces the duration of hospitalization and infection in both mothers and neonates.


Assuntos
Ruptura Prematura de Membranas Fetais/terapia , Pulmão/embriologia , Adulto , Corioamnionite/epidemiologia , Feminino , Morte Fetal/etiologia , Ruptura Prematura de Membranas Fetais/epidemiologia , Monitorização Fetal , Maturidade dos Órgãos Fetais , Seguimentos , Humanos , Incidência , Infusões Intravenosas , Trabalho de Parto Induzido , Tempo de Internação , Morbidade , Ocitocina/administração & dosagem , Ocitocina/uso terapêutico , Exame Físico , Gravidez , Complicações na Gravidez/epidemiologia , Resultado da Gravidez , Terceiro Trimestre da Gravidez , Estudos Prospectivos , Tocólise
3.
J Antimicrob Chemother ; 12 Suppl C: 105-16, 1983 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-6358179

RESUMO

The effect of clindamycin on growth and haemolysin production by four strains of Escherichia coli was tested. Clindamycin MICs were greater than 256 mg/l for all strains. Clindamycin concentrations of 16-256 mg/l significantly inhibited growth, while concentrations from 2-32 mg/l significantly inhibited haemolysin production. Administration of clindamycin to rats with peritonitis due to haemolytic E. coli reduced mortality. Subinhibitory concentrations of clindamycin can inhibit growth and haemolysin production by E. coli and reduce mortality in an animal model of haemolytic E. coli peritonitis.


Assuntos
Clindamicina/farmacologia , Escherichia coli/efeitos dos fármacos , Proteínas Hemolisinas/biossíntese , Animais , Clindamicina/sangue , Eritrócitos/efeitos dos fármacos , Escherichia coli/crescimento & desenvolvimento , Escherichia coli/metabolismo , Técnicas In Vitro , Masculino , Testes de Sensibilidade Microbiana , Coelhos , Ratos , Ratos Endogâmicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...